The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation.

Saved in:
Bibliographic Details
Title: The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation.
Authors: Shaaban FL; Department of Paediatric Immunology and Infectious Diseases, University Medical Centre Utrecht, Utrecht, Netherlands., Groenendijk RW; Department of Paediatric Immunology and Infectious Diseases, University Medical Centre Utrecht, Utrecht, Netherlands., Baral R; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Caballero MT; Escuela de Bio y Nanotecnologías, Universidad Nacional de San Martín Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina., Crowe JE Jr; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, TN, USA., Englund JA; Department of Pediatrics, University of Washington and Seattle Children's Research Institute, Seattle, WA, USA., Esteban I; Gavi, the Vaccine Alliance, Geneva, Switzerland., Hirve S; Global Influenza Programme, WHO, Geneva, Switzerland., Jit M; Department of Global and Environmental Health, School of Global Public Health, New York University, New York, NY, USA., Kalergis AM; Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Departamento de Endocrinología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Karron RA; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Lukacs N; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Martinon-Torres F; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, University of Santiago and Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Galicia, Spain., Mejias A; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA., Nair H; Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, UK., Nisar MI; Department of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan., Nyiro JU; Department of Epidemiology and Demography, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya., Pecenka C; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Sparrow E; WHO, Geneva, Switzerland., Srikantiah P; Gates Foundation, Seattle, WA, USA., Thwaites RS; National Heart and Lung Institute, Imperial College London, London, UK., Zar HJ; Department of Pediatrics and Child Health, Red Cross War Memorial Children's Hospital and SA-MRC unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa., Bont LJ; Department of Paediatric Immunology and Infectious Diseases, University Medical Centre Utrecht, Utrecht, Netherlands; ReSViNET Foundation, Julius Clinical, Zeist, Netherlands. Electronic address: l.bont@umcutrecht.nl.
Source: The Lancet. Global health [Lancet Glob Health] 2025 Dec; Vol. 13 (12), pp. e2165-e2174. Date of Electronic Publication: 2025 Nov 03.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2214-109X
DOI:10.1016/S2214-109X(25)00379-1